Jupiter Life Line Hospitals last traded at ₹251.35 (2026-10-13). Over the past month the stock moved -10.5%, three months the stock moved +0.6%, year the stock moved -16.8%. Its closing range over 52 weeks is ₹242.34 – ₹322.40, with the latest close 22.0% below the high.
Closing prices up to 2026-10-13.
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
Hospital Portfolio:[1][2] The company operates 4 hospitals across Thane, Pune, Indore & Dombivli with 1,248 operational beds (Census Beds and Non-Census Beds: 140).
In the latest quarter (Jun 2026), Jupiter Life Line Hospitals reported sales of ₹411.00 crore (+16.4%) and net profit of ₹38.00 crore (-13.6%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 411.00 | 79.00 | 19.00 | 38.00 | 1.14 |
| Mar 2026 | 388.00 | 89.00 | 23.00 | 50.00 | 1.53 |
| Dec 2025 | 365.00 | 83.00 | 23.00 | 42.00 | 1.30 |
| Sep 2025 | 394.00 | 92.00 | 23.00 | 57.00 | 1.75 |
| Jun 2025 | 353.00 | 78.00 | 22.00 | 44.00 | 1.34 |
| Mar 2025 | 337.00 | 80.00 | 24.00 | 45.00 | 1.38 |
| Dec 2024 | 333.00 | 76.00 | 23.00 | 52.00 | 1.59 |
| Sep 2024 | 335.00 | 78.00 | 23.00 | 52.00 | 1.58 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +27.4% | +22.0% | +15.8% | +22.1% | +17.6% | +9.6% | +15.1% | +16.4% |
| Operating profit growth | +27.9% | +22.6% | +27.0% | +20.0% | +17.9% | +9.2% | +11.3% | +1.3% |
| Net profit growth | +52.9% | +18.2% | +0.0% | -2.2% | +9.6% | -19.2% | +11.1% | -13.6% |
| EPS growth | +53.4% | +19.5% | +0.7% | -1.5% | +10.8% | -18.2% | +10.9% | -14.9% |
| OPM % | 23.0% | 23.0% | 24.0% | 22.0% | 23.0% | 23.0% | 23.0% | 19.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Jupiter Life Line Hospitals reported sales of ₹1,500.00 crore (+18.9%) and net profit of ₹194.00 crore (+0.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 1,500 | 343.00 | 23.00 | 194.00 | 29.59 |
| Mar 2025 | 1,262 | 297.00 | 24.00 | 194.00 | 29.51 |
| Mar 2024 | 1,073 | 242.00 | 23.00 | 177.00 | 26.94 |
| Mar 2023 | 893.00 | 201.00 | 23.00 | 73.00 | 12.90 |
| Mar 2022 | 733.00 | 153.00 | 21.00 | 51.00 | 10.05 |
| Mar 2021 | 486.00 | 67.00 | 14.00 | -2.00 | -0.45 |
| Mar 2020 | 463.00 | 84.00 | 18.00 | 30.00 | 5.83 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales growth | +5.0% | +50.8% | +21.8% | +20.2% | +17.6% | +18.9% |
| Operating profit growth | -20.2% | +128.4% | +31.4% | +20.4% | +22.7% | +15.5% |
| Net profit growth | -106.7% | – | +43.1% | +142.5% | +9.6% | +0.0% |
| EPS growth | -107.7% | – | +28.4% | +108.8% | +9.5% | +0.3% |
| OPM % | 14.0% | 21.0% | 23.0% | 23.0% | 24.0% | 23.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Jupiter Life Line Hospitals.
Get Free AI Stock Analysis FREE →Jupiter Life Line Hospitals: Prabhudas Lilladher Projects 17% EBITDA CAGR - Whalesbook
Jupiter Life Line Hospitals drops after Q1 PAT tumbles 15% YoY to Rs 37 cr - Business Standard
Jupiter Life Line Hospitals consolidated net profit declines 14.58% in the June 2026 quarter - Business Standard
Jupiter Life Line reports Profit after tax of Rs 371.89 Mln, in the June 2026 quarter
Jupiter Life Line Hospitals shares jump nearly 6% following block deal; all you need to know
Jupiter Life Line Hospitals shares jump nearly 6% following block deal; all you need to know
Jupiter Life Line Hospitals board approves 1:5 stock split, interim dividend; check key Q4 numbers
Jupiter Life Line Hospitals board approves 1:5 stock split, interim dividend; check key Q4 numbers
Jupiter Life Line Hospitals acquires land for proposed hospital at BKC, Mumbai - Business Standard
Jupiter Life Line Hospitals acquires land for proposed hospital at BKC, Mumbai - Business Standard
Jupiter Life Line Hospitals shares were last quoted at ₹251.35 (-1.7% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Jupiter Life Line Hospitals has a price-to-earnings (P/E) ratio of 46.34 and a price-to-book (P/B) ratio of 5.63. The industry P/E is 101.02.
The 52-week high of Jupiter Life Line Hospitals is ₹337.90 and the 52-week low is ₹230.41.
The market capitalisation of Jupiter Life Line Hospitals is about ₹8,689.14 crore.
In the latest quarter (Jun 2026), Jupiter Life Line Hospitals reported sales of ₹411.00 crore (+16.4%) and net profit of ₹38.00 crore (-13.6%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Jupiter Life Line Hospitals has a 3-year ROE of 16.00%, 3-year profit growth of 37.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 40.91% of Jupiter Life Line Hospitals.
Jupiter Life Line Hospitals belongs to the Hospital & Healthcare Services sector.
All Hospital & Healthcare Services stocks · Browse all stocks A–Z